News

Successful Exit Lunaphore

We are excited to announce the upcoming exit of our portfolio company Lunaphore Technologies. Lunaphore is a Lausanne-based life sciences company developing technologies to enable spatial biology in any laboratory.

The company announced that it has entered into an agreement to be acquired by Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company. The acquisition is expected to close in Q3 and is the next logical step after the two companies recently entered into a strategic partnership to develop the first fully automated spatial multiomics workflow.

We are very proud to have been one of the early investors since 2016 and to be part of this fascinating success story driven by a brilliant founding team. Congratulations to Ata, Déborah and Diego, and the entire Lunaphore team on this great success!

More information in the press release under the following Link

More about Lunaphore

Initial Investment in EBAMed Overview Thermosome receives important grant
Want to learn more about OCCIDENT?

News